Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation

Lignende værker

• Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
  af: Cani, Alice, et al.
  Udgivet: (2015)
• Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia
  af: Simioni, Carolina, et al.
  Udgivet: (2016)
• The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
  af: Simioni, Carolina, et al.
  Udgivet: (2015)
• Healthy CD4(+) T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia
  af: Alameen, Ayman A.M., et al.
  Udgivet: (2016)
• Targeting mTOR in Acute Lymphoblastic Leukemia
  af: Simioni, Carolina, et al.
  Udgivet: (2019)